15th Annual Meeting of the Oligonucleotide Therapeutics Society, Munich, Germany
InteRNA Technologies will present 2 posters at the Oligonucleotide Therapeutics Society (OTS) annual meeting:
Sunday, October 13th during Poster Session I from 18.00-19.30
Poster #27 by Thijs de Gunst, MSc, Manager Preclinical Operations:
A.188 A novel lipid-based nanoparticle formulation mediating safe and robust functional delivery of siRNA/miRNA.
DE GUNST, T., YAHYANEJAD, S., DEN BOER, H., VOS, R., ALEMDEHY, F., TELFORD, B., VAN DEN BOSCH, M., STEGINK, M., VAN PINXTEREN, L., SCHAAPVELD, R. & JANICOT, M.
Monday, October 14th during Poster Session II from 17.35-19.30
Poster #138 by Marion van den Bosch, PhD, Scientist:
A.187 Transcriptome-wide analysis reveals novel insights into tumor suppressor function of 1B3 (a chemically-modified miR-193a-3p mimic).
VAN DEN BOSCH, M., YAHYANEJAD, S., ALEMDEHY, F., TELFORD, B., DE GUNST, T., DEN BOER, H., VOS, R., STEGINK, M., VAN PINXTEREN, L., SCHAAPVELD, R. & JANICOT, M.